Rhodacyanine Derivative Selectively Targets Cancer Cells and Overcomes Tamoxifen Resistance

John Koren(University of South Florida), Chad A. Dickey(University of South Florida)
PLoS ONE
April 26, 2012
Cited by 51


Related Papers